MSc PMP - RepliCel Life Clinical Consultant
| RP Stock | CAD 0.01 0.00 0.00% |
Insider
MSc PMP is Clinical Consultant of RepliCel Life Sciences
| Age | 50 |
| Address | 570 Granville Street, Vancouver, BC, Canada, V6C 3P1 |
| Phone | 604 248 8730 |
| Web | https://www.replicel.com |
RepliCel Life Management Efficiency
The company has return on total asset (ROA) of (1.5334) % which means that it has lost $1.5334 on every $100 spent on assets. This is way below average. RepliCel Life's management efficiency ratios could be used to measure how well RepliCel Life manages its routine affairs as well as how well it operates its assets and liabilities. At this time, RepliCel Life's Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to climb to 0.07 in 2024, whereas Return On Tangible Assets are likely to drop (1.14) in 2024. At this time, RepliCel Life's Other Current Assets are fairly stable compared to the past year. Debt To Assets is likely to climb to 3.19 in 2024, whereas Non Current Assets Total are likely to drop slightly above 119.4 K in 2024.Similar Executives
| Found 6 records | INSIDER Age | ||
| Graeme Dick | biOasis Technologies | N/A | |
| Dave Jenkins | biOasis Technologies | N/A | |
| B FTSE | biOasis Technologies | 64 | |
| Kim Elton | biOasis Technologies | N/A | |
| Doug MBA | biOasis Technologies | N/A | |
| Mei Tian | biOasis Technologies | N/A | |
Management Performance
| Return On Asset | -1.53 |
RepliCel Life Sciences Leadership Team
Elected by the shareholders, the RepliCel Life's board of directors comprises two types of representatives: RepliCel Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RepliCel. The board's role is to monitor RepliCel Life's management team and ensure that shareholders' interests are well served. RepliCel Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, RepliCel Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| BA CPA, Chief Officer | ||
| Kevin McElwee, Chief Scientific Officer | ||
| MSc PMP, Clinical Consultant | ||
| Ben Austring, Corporate Officer | ||
| David CPA, Chief Officer | ||
| Andrew Schutte, CEO President | ||
| BEd LLB, Corp Director | ||
| Rolf MD, Chief Board |
RepliCel Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is RepliCel Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RepliCel Stock Analysis
When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.